11,391 Shares in Ralliant Corporation $RAL Acquired by Royce & Associates LP

Royce & Associates LP bought a new position in shares of Ralliant Corporation (NYSE:RAL) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 11,391 shares of the company’s stock, valued at approximately $580,000.

Several other institutional investors have also modified their holdings of the business. Pinnbrook Capital Management LP purchased a new stake in shares of Ralliant during the fourth quarter worth $7,878,000. Covestor Ltd boosted its holdings in Ralliant by 4,096.7% in the fourth quarter. Covestor Ltd now owns 11,583 shares of the company’s stock valued at $590,000 after purchasing an additional 11,307 shares during the period. Gabelli Funds LLC grew its stake in Ralliant by 11.9% during the 4th quarter. Gabelli Funds LLC now owns 29,836 shares of the company’s stock worth $1,519,000 after purchasing an additional 3,177 shares in the last quarter. Thrivent Financial for Lutherans grew its stake in Ralliant by 3.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 218,251 shares of the company’s stock worth $11,111,000 after purchasing an additional 8,206 shares in the last quarter. Finally, Allworth Financial LP increased its holdings in Ralliant by 134.4% during the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the period.

Wall Street Analyst Weigh In

RAL has been the subject of several recent research reports. Morgan Stanley lifted their price objective on Ralliant from $45.00 to $68.00 and gave the company an “overweight” rating in a research note on Thursday, May 14th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ralliant in a report on Monday, May 4th. Citigroup lifted their price target on shares of Ralliant from $51.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Royal Bank Of Canada boosted their price target on shares of Ralliant from $47.00 to $64.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 13th. Finally, Wall Street Zen downgraded shares of Ralliant from a “buy” rating to a “hold” rating in a research report on Sunday. Six research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $64.50.

Insider Activity

In related news, SVP Karen M. Bick sold 5,485 shares of the stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total value of $246,825.00. Following the transaction, the senior vice president directly owned 46,756 shares of the company’s stock, valued at $2,104,020. This trade represents a 10.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.42% of the company’s stock.

Ralliant Trading Down 0.1%

RAL opened at $61.84 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. Ralliant Corporation has a one year low of $37.27 and a one year high of $62.95. The company has a market cap of $6.92 billion and a P/E ratio of -5.65. The business’s 50-day simple moving average is $48.80 and its 200-day simple moving average is $48.70.

Ralliant (NYSE:RAL) last posted its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.08. The firm had revenue of $534.60 million during the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. As a group, equities research analysts expect that Ralliant Corporation will post 2.64 EPS for the current fiscal year.

Ralliant Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th will be issued a $0.05 dividend. The ex-dividend date is Monday, June 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant’s dividend payout ratio is presently -1.83%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.